Table 1.
Baseline characteristics of the study population.
| Parameter | TNC 5 mg |
TNC 15 mg |
TNC 30 mg |
Synthetic Lycopene 15 mg |
Placebo | All |
|---|---|---|---|---|---|---|
| Age (years) 1 | 53.5 ± 8.0 (12) | 54.0 ± 8.6 (12) | 51.0 ± 10.1 (13) | 52.1 ± 8.4 (12) | 51.8 ± 6.3 (12) | 52.4 ± 8.2 (61) |
| Males (%) | 66.7% (8) | 75.0% (9) | 69.2% (9) | 66.7% (8) | 83.3% (10) | 72.1% (44) |
| Females (%) | 33.3% (4) | 25.0% (3) | 30.8 (4) | 33.3% (4) | 16.7% (2) | 27.9% (17) |
| SBP (mmHg) 1 | 133.6 ± 7.8 (12) | 137.4 ± 5.6 (12) | 136.4 ± 7.8 (13) | 132.8 ± 9.3 (12) | 135.7 ± 6.0 (12) | 135.2 ± 7.4 (61) |
| DBP (mmHg) 1 | 82.9 ± 9.3 (12) | 83.8 ± 6.3 (12) | 77.5 ± 21 (13) | 82.3 ± 6.1 (12) | 83.7 ± 8.7 (12) | 82.0 ± 11.7 (61) |
| Plasma lycopene (µM) | 0.97 ± 0.49 (7) | 1.55 ± 0.86 (7) | 0.80 ± 0.74 (10) | 0.91 ± 0.95 (8) | 1.01 ± 1.24 (10) | 0.93 ± 0.68 (42) |
| TG (mg/dL) | 152.0 ± 70.4 (11) | 164.3 ± 65.3 (10) | 124.5 ± 75.3 (12) | 115.1 ± 50.5 (10) | 166.0 ± 103.1 (12) | |
| HDL chol (mg/dL) | 52.0 ± 12.2 (10) | 49.5 ± 10.1 (10) | 54.4 ± 10.0 (12) | 59.1 ± 18.2 (10) | 52.1 ± 11.7 (11) | |
| LDL chol (mg/dL) | 142.1 ± 34.6 (10) | 107.4 ± 26.0 (9) | 104.8 ± 31.1 (11) | 134.2 ± 29.5 (10) | 112.9 ± 30.1 (9) |
1 Age, BP, lycopene, TG, HDL, and LDL values are mean ± SD (N).